Helminthiasis: Clinical Trials

62 trials for Helminthiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed, 6 unknown, 4 not yet recruiting, 4 terminated. 62 Phase 2, 13 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 262Completed 43, Unknown 6, Not yet recruiting 4, Terminated 4, Withdrawn 3, Active not recruiting 1, Recruiting 1
Phase 313Completed 8, Not yet recruiting 2, Terminated 2, Unknown 1
Phase 13Completed 2, Unknown 1

Follow Helminthiasis: new trials by email Literature Review of Helminthiasis trials Research Report on Helminthiasis

Trials (filtered) newest first · largest first

All 62 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oxfendazole in Mild Parenchymal Brain Cysticercosis
Oxfendazole single dose, Oxfendazole three doses, albendazole plus praziquantel regime - Brain Cysticercosis
Phase 2 / Phase 3Not yet recruitingUniversidad Peruana Cayetano Heredia5442026-12-012026-05-01
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Emodepside, Albendazole 400 mg - Trichuris Infection
Phase 2Not yet recruitingJennifer Keiser1002026-11-152026-08-14
Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis
Praziquantel 40 mg/kg per dose given once annually, Praziquantel 40 mg/kg given three times per year - Schistosomiasis, Schistosoma Mansoni
Phase 2 / Phase 3Not yet recruitingRhode Island Hospital6002026-11-012026-08-12
One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis
Oxfendazole, Triclabendazole - Fascioliasis
Phase 2Not yet recruitingUniversidad Peruana Cayetano Heredia3362026-08-152026-06-03
Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura
Oxantel Pamoate, Mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 2CompletedJennifer Keiser1632025-04-162025-06-08
A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults
Albendazole, Oxfendazole - Trichuriasis
Phase 2RecruitingAsociacion Benefica Prisma2492024-09-072026-07-28
Sm-p80 Schistosomiasis Challenge Study
Sm-p80 + GLA-SE Vaccine, Placebo, Schistosoma mansoni infection - Schistosoma Mansoni, Schistosomiasis
Phase 2UnknownLeiden University Medical Center482024-09-012023-10-17
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
Oxfendazole, Albendazole - Trichuris Infection
Phase 2WithdrawnOxfendazole Development Group2024-07-012026-11-06
A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects
Levamisole 3 days, Levamisole 5 days, Placebo - Loiasis
Phase 2 / Phase 3UnknownProgramme National de Lutte contre l'Onchocercose, Republic of the Congo992024-06-212024-09-20
Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC
Ivermectin 1.5 mg ODT, Ivermectin 3 mg Oral Tablet, Albendazole 400 mg Oral Tablet - Trichuriasis, Ascariasis
Phase 2CompletedJennifer Keiser2602024-06-052025-09-22
Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis
Emodepside - Strongyloides Stercoralis Infection, Strongyloidiasis
Phase 2CompletedSwiss Tropical & Public Health Institute2022024-05-202024-11-20
Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis
Ivermectin w/ Albendazole, Ivermectin + Diethylcarbamazine + Albendazole, Moxidectin + Albendazole - Onchocercal Subcutaneous Nodule, Onchocerciasis
Phase 2Active not recruitingWashington University School of Medicine3002024-04-052025-12-18
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm
Emodepside, Albendazole 400mg - Hookworm Infections
Phase 2CompletedJennifer Keiser3202022-09-162023-06-15
Anti-Schistosomiasis Sm14-vaccine in Senegal
Sm14 recombinant vaccine+ GLA-SE adjuvant - Schistosomiasis Mansoni, Schistosomiasis Haematobium
Phase 2UnknownOswaldo Cruz Foundation1202022-07-012022-12-21
Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Moxidectin 2 MG Oral Tablet, Ivermectin 3Mg Tab, Placebo oral tablet - Onchocerciasis, Ocular, Loiasis
Phase 2CompletedCenter for Research on Filariasis and Other Tropical Diseases, Cameroon722022-04-072025-02-24
Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms
Albendazole and Ivermectin fixed dose coformulation, Albendazole - Helminthes; Infestation, Intestinal
Phase 2 / Phase 3TerminatedBarcelona Institute for Global Health10012022-01-202025-09-22
Emodepside Phase II Trial for Treatment of Onchocerciasis
emodepside, matching placebo of emodepside, ivermectin - Onchocerciasis
Phase 2UnknownDrugs for Neglected Diseases5782021-08-302024-03-05
Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm
Emodepside - Trichuris Trichiura; Infection, Hookworm Infections
Phase 2CompletedJennifer Keiser4422021-08-022022-05-27
Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection
ABBV-4083, Placebo for ABBV-4083, Albendazole - Onchocerciasis
Phase 2TerminatedAbbVie1532021-05-222024-09-19
Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni
Ujiplus®, Praziquantel 400mg - Schistosoma Mansoni
Phase 2 / Phase 3CompletedKenya Medical Research Institute4002021-05-062022-07-12

Showing 20 of 62. Sign in to see all of them.

Narrower conditions

Schistosomiasis (13)  ·  Trichuriasis (11)  ·  Hookworm Infections (9)  ·  Onchocerciasis (8)  ·  Onchocerciasis, Ocular (7)  ·  Ancylostomiasis (6)  ·  Elephantiasis, Filarial (6)  ·  Loiasis (5)  ·  Schistosomiasis haematobia (4)  ·  Filariasis (3)  ·  Neurocysticercosis (3)  ·  Schistosomiasis mansoni (3)  ·  Ascariasis (2)  ·  Mansonelliasis (2)

Broader conditions

Infections (61)  ·  Parasitic Diseases (61)  ·  Nematode Infections (36)  ·  Secernentea Infections (31)  ·  Vector Borne Diseases (30)  ·  Spirurida Infections (20)  ·  Trematode Infections (18)  ·  Filariasis (17)  ·  Adenophorea Infections (11)  ·  Enoplida Infections (11)  ·  Skin and Connective Tissue Diseases (11)  ·  Skin Diseases (10)  ·  Strongylida Infections (10)  ·  Skin Diseases, Infectious (9)

Interventions

Albendazole (23)  ·  Ivermectin (13)  ·  Praziquantel (9)  ·  moxidectin (6)  ·  Diethylcarbamazine (5)  ·  emodepside (5)  ·  oxfendazole (5)  ·  Tablets (4)  ·  Albumins (2)  ·  Azithromycin (2)  ·  Doxycycline (2)  ·  Levamisole (2)  ·  Mebendazole (2)  ·  SM14 protein, Schistosoma mansoni (2)  ·  glucopyranosyl lipid-A (2)

Sponsors

Jennifer Keiser (8)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (7)  ·  Universidad Peruana Cayetano Heredia (4)  ·  Oswaldo Cruz Foundation (3)  ·  Swiss Tropical & Public Health Institute (3)  ·  Baylor College of Medicine (2)  ·  Kenya Medical Research Institute (2)  ·  Programme National de Lutte contre l'Onchocercose, Republic of the Congo (2)  ·  Rhode Island Hospital (2)  ·  Washington University School of Medicine (2)  ·  AbbVie (1)  ·  Albert Schweitzer Hospital (1)  ·  Alejandro Krolewiecki (1)  ·  Asociacion Benefica Prisma (1)  ·  Barcelona Institute for Global Health (1)

Countries

Tanzania (8)  ·  Uganda (5)  ·  Ghana (4)  ·  United States (4)  ·  Peru (3)  ·  Senegal (3)  ·  Cameroon (2)  ·  Côte d’Ivoire (2)  ·  Democratic Republic of the Congo (2)  ·  Gabon (2)  ·  India (2)  ·  Kenya (2)  ·  Laos (2)  ·  Mali (2)  ·  Papua New Guinea (2)

Top investigators

Elijah M Songok, PhD (2)  ·  Gary Weil, MD (2)  ·  Hector H Garcia, MD, PhD (2)  ·  Jennifer Keiser, PhD (2)  ·  Miriam Tendler, MD, PhD (2)  ·  Alejandro J Krolewiecki, MD, PhD (1)  ·  Alexander Loukas, PhD (1)  ·  Alexander Y Debrah, PhD (1)  ·  Alison Elliot (1)  ·  Allen Nalugwa, PhD (1)  ·  Amy D Klion, M.D. (1)  ·  Annette Olsen, PhD (1)

Results publications

PMID 19150418, PMID 2022660, PMID 21298114, PMID 23284726, PMID 26571311, PMID 33998661, PMID 19802383, PMID 19812401, PMID 21332573, PMID 23175561, PMID 24968000, PMID 24999157, PMID 26486704, PMID 26511959, PMID 26984901, PMID 27441564, PMID 28061905, PMID 28472067, PMID 29546300, PMID 30403937, PMID 30469320, PMID 30526582, PMID 30687792, PMID 30878222, PMID 30885157, PMID 31044235, PMID 31188820, PMID 32405623, PMID 32668456, PMID 32818264, PMID 33150325, PMID 33188747, PMID 33861768, PMID 33906234, PMID 34191812, PMID 34632308, PMID 34651190, PMID 34856181, PMID 35217670, PMID 35788749, PMID 36315579, PMID 36342912, PMID 36354034, PMID 36540062, PMID 37195942, PMID 37195949, PMID 37205721, PMID 37262040, PMID 38517907, PMID 38966851

NIH funding

R01AI184979 (1), R01HD095562 (1), R01NS054805 (1), U01AI129789 (1), U01AI155323 (1)